40 related articles for article (PubMed ID: 32079046)
1. Integrative analysis of metabolomics and proteomics reveals mechanism of berberrubine-induced nephrotoxicity.
Rao J; Wang T; Wang K; Qiu F
Toxicol Appl Pharmacol; 2024 Jul; 488():116992. PubMed ID: 38843998
[TBL] [Abstract][Full Text] [Related]
2. Advances in predictive in vitro models of drug-induced nephrotoxicity.
Soo JY; Jansen J; Masereeuw R; Little MH
Nat Rev Nephrol; 2018 Jun; 14(6):378-393. PubMed ID: 29626199
[TBL] [Abstract][Full Text] [Related]
3. Blood Biomarkers and Metabolomic Profiling for the Early Diagnosis of Vancomycin-Associated Acute Kidney Injury: A Systematic Review and Meta-Analysis of Experimental Studies.
Laou E; Mavridis T; Papagiannakis N; Pais G; Chighine A; Chang J; Locci E; D'Aloja E; Scheetz M; Chalkias A; Xanthos T
J Pers Med; 2022 Aug; 12(9):. PubMed ID: 36143182
[TBL] [Abstract][Full Text] [Related]
4. A GC-MS-based untargeted metabolomics approach for comprehensive metabolic profiling of vancomycin-induced toxicity in mice.
Cui C; Zhu L; Wang Q; Liu R; Xie D; Guo Y; Yu D; Wang C; Chen D; Jiang P
Heliyon; 2022 Jul; 8(7):e09869. PubMed ID: 35855991
[TBL] [Abstract][Full Text] [Related]
5. Population Pharmacokinetics Modeling of Vancomycin Among Chinese Infants With Normal and Augmented Renal Function.
Li DY; Li L; Li GZ; Hu YH; Guo HL; Jing X; Chen F; Ji X; Xu J; Dai HR
Front Pediatr; 2021; 9():713588. PubMed ID: 34616698
[TBL] [Abstract][Full Text] [Related]
6. Metabolic and Lipidomic Assessment of Kidney Cells Exposed to Nephrotoxic Vancomycin Dosages.
Lagies S; Pichler R; Vladimirov G; Gawron J; Bäzner F; Schreiner A; Kadena D; Plattner DA; Lienkamp SS; Kammerer B
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576273
[TBL] [Abstract][Full Text] [Related]
7. Renoprotective Effects of Melatonin against Vancomycin-Related Acute Kidney Injury in Hospitalized Patients: a Retrospective Cohort Study.
Hong TS; Briscese K; Yuan M; Deshpande K; Aleksunes LM; Brunetti L
Antimicrob Agents Chemother; 2021 Aug; 65(9):e0046221. PubMed ID: 34152824
[TBL] [Abstract][Full Text] [Related]
8. Vancomycin-induced nephrotoxicity: mechanism, incidence, risk factors and special populations. A literature review.
Elyasi S; Khalili H; Dashti-Khavidaki S; Mohammadpour A
Eur J Clin Pharmacol; 2012 Sep; 68(9):1243-55. PubMed ID: 22411630
[TBL] [Abstract][Full Text] [Related]
9. Vancomycin-associated renal dysfunction: where are we now?
Carreno JJ; Kenney RM; Lomaestro B
Pharmacotherapy; 2014 Dec; 34(12):1259-68. PubMed ID: 25220436
[TBL] [Abstract][Full Text] [Related]
10. New insights into the vancomycin-induced nephrotoxicity using in vitro metabolomics combined with physiologically based pharmacokinetic modeling.
Du H; Li Z; Yang Y; Li X; Wei Y; Lin Y; Zhuang X
J Appl Toxicol; 2020 Jul; 40(7):897-907. PubMed ID: 32079046
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for vancomycin nephrotoxicity and time course of renal function during vancomycin treatment.
Hirai T; Hanada K; Kanno A; Akashi M; Itoh T
Eur J Clin Pharmacol; 2019 Jun; 75(6):859-866. PubMed ID: 30770940
[TBL] [Abstract][Full Text] [Related]
12. In vivo evidences suggesting the role of oxidative stress in pathogenesis of vancomycin-induced nephrotoxicity: protection by erdosteine.
Oktem F; Arslan MK; Ozguner F; Candir O; Yilmaz HR; Ciris M; Uz E
Toxicology; 2005 Nov; 215(3):227-33. PubMed ID: 16112787
[TBL] [Abstract][Full Text] [Related]
13. Development of a Physiologically Based Pharmacokinetic Modelling Approach to Predict the Pharmacokinetics of Vancomycin in Critically Ill Septic Patients.
Radke C; Horn D; Lanckohr C; Ellger B; Meyer M; Eissing T; Hempel G
Clin Pharmacokinet; 2017 Jul; 56(7):759-779. PubMed ID: 28039606
[TBL] [Abstract][Full Text] [Related]
14. Relationship between initial vancomycin concentration-time profile and nephrotoxicity among hospitalized patients.
Lodise TP; Patel N; Lomaestro BM; Rodvold KA; Drusano GL
Clin Infect Dis; 2009 Aug; 49(4):507-14. PubMed ID: 19586413
[TBL] [Abstract][Full Text] [Related]
15. The Relationship of nephrotoxicity to vancomycin trough serum concentrations in a veteran's population: a retrospective analysis.
Horey A; Mergenhagen KA; Mattappallil A
Ann Pharmacother; 2012 Nov; 46(11):1477-83. PubMed ID: 23073306
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
